Cargando…
KINETICS OF ANTI-SARS-COV-2 IGG ANTIBODIES POST-COVID-19 -VACCINATION
INTRO: During the pandemic of COVD-19, several vaccines have been developed and are currently used worldwide. However, head-to-head studies comparing various vaccines are limited. Therefore, This single-center, prospective, realworld study. head-to-head study of compared the effectiveness of BNT162b...
Autores principales: | Kamal, S., Naguib, M., Daador, M., Alanazi, Z., Basalem, A. Abdullah, Alaskar, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186921/ http://dx.doi.org/10.1016/j.ijid.2023.04.208 |
Ejemplares similares
-
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study
por: Kamal, Sanaa M., et al.
Publicado: (2023) -
Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines
por: Ebrahim, Fawzi, et al.
Publicado: (2022) -
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
por: Tretyn, Andrzej, et al.
Publicado: (2021) -
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022) -
Kinetics of Anti–SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection
por: Sakhi, Hamza, et al.
Publicado: (2021)